Also called: Christmas disease · Factor IX deficiency · Factor VIII deficiency
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Hemophilia
Hemophilia is a rare bleeding disorder in which the blood does not clot properly. This can lead to problems with bleeding too much after an injury or surgery. You can also have sudden bleeding inside your body, such as in your joints, muscles, and organs.
Your blood contains many proteins called clotting factors that can help form clots to stop bleeding. People with hemophilia have low levels of one of these factors, usually either factor VIII (8) or factor IX (9). How severe the hemophilia is depends on the amount of factor in the blood. The lower the amount of the factor, the more likely it is that bleeding could happen and might lead to serious health problems.
There are several different types of hemophilia. The most common are:
- Hemophilia A (classic hemophilia), which is caused by a lack or decrease of clotting factor VIII (8)
- Hemophilia B (Christmas disease), which is caused by a lack or decrease of clotting factor IX (9)
Most types of hemophilia are inherited. They are caused by change in one of the genes (also called a mutation) that provides instructions for making the clotting factor proteins. The change may mean that the clotting proteins don't work properly or that they are missing altogether.
These genes are on the X chromosome. You may have one or two X chromosomes:
- People who are born male have one X chromosome (from the mother) and one Y chromosome (from the father). They can get hemophilia if their one X chromosome has the gene change.
- People who are born female have two X chromosomes, one from the father and one from the mother. They usually only get hemophilia if: Both X chromosomes have the gene change OR
- One X chromosome has the gene change and the other X chromosome is missing or inactive.
People who are born female who have the gene change on one X chromosome are a "carrier" of hemophilia. Sometimes they may have some symptoms of hemophilia. They can pass the gene change on to their children.
Hemophilia that is not inherited is called acquired hemophilia. It is rare. It happens when your body makes specialized proteins called autoantibodies that attack and disable a clotting factor. This can happen because of pregnancy, immune system disorders, cancer, or allergic reactions to certain medicines. Sometimes the cause is unknown.
Hemophilia is much more common in people who were born male since they can get it with a change to the gene on one X chromosome. People who have a family history of hemophilia are also at higher risk.
The signs and symptoms of hemophilia are:
- Bleeding into the joints. This can cause swelling and pain or tightness in the joints. It often affects the knees, elbows, and ankles.
- Bleeding into the skin (which is bruising).
- Bleeding into the muscle and soft tissue, which can cause a build-up of blood in the area (called a hematoma).
- Bleeding of the mouth and gums, including bleeding that is hard to stop after you lose a tooth.
- Bleeding after circumcision.
- Bleeding after having shots, such as vaccinations.
- Bleeding in the head of an infant after a difficult delivery.
- Blood in the urine or stool.
- Frequent and hard-to-stop nosebleeds.
In some cases, severe hemophilia may cause bleeding in the brain. This may cause brain damage and can be life-threatening.
To find out if you have hemophilia, your health care provider will:
- Ask about your medical history, including your symptoms and other health conditions you may have.
- Ask about your family history, to find out if you have relatives who have or had hemophilia.
- Do a physical exam to look for signs of hemophilia, such as bruising.
- Do certain blood tests to show if your blood is clotting properly. If it does not, then you will have clotting factor tests to diagnose the cause of the bleeding disorder. These blood tests would show the type of hemophilia and the severity.
There is genetic testing for the factor VIII (8) and factor IX (9) genes. This testing may be used in people who have a family history of hemophilia to:
- Identify people who are carriers before they make decisions about pregnancy
- Test a fetus for hemophilia during pregnancy
- Test a newborn for hemophilia
The best way to treat hemophilia is to replace the missing clotting factor so that your blood can clot properly. This is usually done by injecting replacement clotting factor into a vein. The replacement clotting factor may be made from donated human blood. Or it may be made in a lab; this kind is called a recombinant clotting factor.
Replacement clotting factor can help treat a bleeding episode. In more severe cases of hemophilia, you might get the factor on a regular basis to prevent bleeding. You can learn how to inject the factor so that you can do it yourself at home.
There are other medicines to treat hemophilia. They may work by releasing factor VIII (8) from where it is stored in the body tissues, replacing the function of factor VIII (8), or preventing clots from breaking down.
If bleeding has damaged your joints, physical therapy may help them function better.
Good quality medical care from healthcare professionals who know a lot about the disorder can help prevent some serious problems. Often the best choice for care is to visit a hemophilia treatment center (HTC).
Centers for Disease Control and Prevention
It sits within Blood, Heart and Circulation and Genetics/Birth Defects.
The lead U.S. institute for this subject is the National Heart, Lung, and Blood Institute.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Hemophilia
988 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Comparison of 30-Second Sit-to-Stand Test Performance Between Individuals With Hemophilia and Healthy PeersBahçeşehir University
- Liver Biopsy Following Gene Therapy For HemophiliaSt. Jude Children's Research Hospital
- Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia ABioverativ, a Sanofi company
- Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)CSL Behring
- A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab ProphylaxisHoffmann-La Roche
- Understanding Treatment Outcomes and Immunologic Mechanisms in Altuviiio Immune Tolerance InductionVersiti Blood Health
Research already completed
- Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX TherapyCSL Behring
- Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior InhibitorsBioMarin Pharmaceutical
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- About HemophiliaNational Human Genome Research Institute
- About HemophiliaCenters for Disease Control and Prevention
- HemophiliaWorld Federation of Hemophilia
- What Are Bleeding DisordersNational Heart, Lung, and Blood Institute
Diagnosis and Tests
- Coagulation Factor TestsNational Library of Medicine
- Diagnosing HemophiliaCenters for Disease Control and Prevention
- Partial Thromboplastin Time (PTT) TestNational Library of Medicine
- Prothrombin Time Test and INR (PT/INR)National Library of Medicine
Treatments and Therapies
- Treatments for Blood DisordersNational Heart, Lung, and Blood Institute
Living With
- Hemophilia: Handling BleedsNemours Foundation
- Living with HemophiliaCenters for Disease Control and Prevention
- Travel Safe with a Bleeding DisorderCenters for Disease Control and Prevention
Related Issues
- Testing for Inhibitors and HemophiliaCenters for Disease Control and Prevention
Genetics
- Hemophilia: MedlinePlus GeneticsNational Library of Medicine
Statistics and Research
- Data and Statistics on HemophiliaCenters for Disease Control and Prevention
Clinical Trials
- ClinicalTrials.gov: Blood Coagulation DisordersNational Institutes of Health
- ClinicalTrials.gov: Hemophilia ANational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Hemophilia A. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Hemophilia, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.